CPRX vs. JNJ
CPRX (Catalyst Pharmaceuticals, Inc.) and JNJ (Johnson & Johnson) are both stocks. Both are in the Healthcare sector — CPRX in Biotechnology, JNJ in Drug Manufacturers - General. Over the past 10 years, CPRX returned 46.26%/yr vs 10.46%/yr for JNJ. At a 0.13 correlation, their price movements are largely independent.
Performance
CPRX vs. JNJ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CPRX achieves a 34.36% return, which is significantly higher than JNJ's 17.68% return. Over the past 10 years, CPRX has outperformed JNJ with an annualized return of 46.26%, while JNJ has yielded a comparatively lower 10.46% annualized return.
CPRX
- 1D
- -0.03%
- 1M
- 0.64%
- YTD
- 34.36%
- 6M
- 32.77%
- 1Y
- 29.11%
- 3Y*
- 39.03%
- 5Y*
- 40.44%
- 10Y*
- 46.26%
JNJ
- 1D
- 1.07%
- 1M
- 5.14%
- YTD
- 17.68%
- 6M
- 15.11%
- 1Y
- 57.60%
- 3Y*
- 17.82%
- 5Y*
- 10.94%
- 10Y*
- 10.46%
CPRX vs. JNJ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CPRX Catalyst Pharmaceuticals, Inc. | 34.36% | 11.84% | 24.15% | -9.62% | 174.74% | 102.69% | -10.93% | 95.31% | -50.90% | 272.38% |
JNJ Johnson & Johnson | 17.68% | 47.48% | -4.81% | -8.58% | 5.97% | 11.44% | 10.82% | 16.22% | -5.13% | 24.43% |
Correlation
The correlation between CPRX and JNJ is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.15 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Nov 8, 2006 | 0.13 |
Fundamentals
CPRX:
$3.98B
JNJ:
$588.98B
CPRX:
$1.74
JNJ:
$8.65
CPRX:
18.02
JNJ:
27.85
CPRX:
0.32
JNJ:
0.93
CPRX:
6.68
JNJ:
6.08
CPRX:
3.93
JNJ:
7.25
CPRX:
$596.96M
JNJ:
$96.36B
CPRX:
$378.23M
JNJ:
$66.60B
CPRX:
$313.50M
JNJ:
$31.62B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CPRX vs. JNJ — Risk / Return Rank
CPRX
JNJ
CPRX vs. JNJ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Catalyst Pharmaceuticals, Inc. (CPRX) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CPRX | JNJ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.53 | ||
| Sortino ratioReturn per unit of downside risk | -3.54 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.61 | -0.43 |
| Calmar ratioReturn relative to maximum drawdown | 1.52 | 5.28 | -3.76 |
| Martin ratioReturn relative to average drawdown | 3.46 | 15.52 | -12.07 |
Loading charts...
Drawdowns
CPRX vs. JNJ - Drawdown Comparison
The maximum CPRX drawdown since its inception was -94.25%, which is greater than JNJ's maximum drawdown of -50.67%. Use the drawdown chart below to compare losses from any high point for CPRX and JNJ.
Loading charts...
Drawdown Indicators
| CPRX | JNJ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.25% | -50.67% | -43.58% |
Max Drawdown (1Y)Largest decline over 1 year | -19.18% | -10.96% | -8.22% |
Max Drawdown (3Y)Largest decline over 3 years | -27.29% | -15.95% | -11.34% |
Max Drawdown (5Y)Largest decline over 5 years | -45.37% | -18.41% | -26.96% |
Max Drawdown (10Y)Largest decline over 10 years | -64.87% | -27.37% | -37.50% |
Current DrawdownCurrent decline from peak | -0.03% | -2.54% | +2.51% |
Average DrawdownAverage peak-to-trough decline | -51.96% | -11.90% | -40.06% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.84% | 3.72% | +6.12% |
Volatility
CPRX vs. JNJ - Volatility Comparison
The current volatility for Catalyst Pharmaceuticals, Inc. (CPRX) is 0.47%, while Johnson & Johnson (JNJ) has a volatility of 5.47%. This indicates that CPRX experiences smaller price fluctuations and is considered to be less risky than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CPRX | JNJ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 0.47% | 5.47% | -5.00% |
Volatility (6M)Calculated over the trailing 6-month period | 23.17% | 12.16% | +11.01% |
Volatility (1Y)Calculated over the trailing 1-year period | 33.28% | 16.94% | +16.34% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 47.77% | 16.87% | +30.90% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 60.39% | 18.48% | +41.91% |
Dividends
CPRX vs. JNJ - Dividend Comparison
CPRX has not paid dividends to shareholders, while JNJ's dividend yield for the trailing twelve months is around 2.18%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CPRX Catalyst Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
JNJ Johnson & Johnson | 2.18% | 2.48% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% |
Financials
CPRX vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between Catalyst Pharmaceuticals, Inc. and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CPRX vs. JNJ - Profitability Comparison
CPRX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Catalyst Pharmaceuticals, Inc. reported a gross profit of 0.00 and revenue of 149.39M. Therefore, the gross margin over that period was 0.0%.
JNJ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a gross profit of 17.20B and revenue of 24.06B. Therefore, the gross margin over that period was 71.5%.
CPRX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Catalyst Pharmaceuticals, Inc. reported an operating income of 73.23M and revenue of 149.39M, resulting in an operating margin of 49.0%.
JNJ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported an operating income of 6.40B and revenue of 24.06B, resulting in an operating margin of 26.6%.
CPRX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Catalyst Pharmaceuticals, Inc. reported a net income of 63.73M and revenue of 149.39M, resulting in a net margin of 42.7%.
JNJ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a net income of 5.24B and revenue of 24.06B, resulting in a net margin of 21.8%.
Frequently Asked Questions
CPRX and JNJ have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
JNJ has higher volatility (5.47%) compared to CPRX (0.47%). In terms of maximum drawdown, CPRX dropped -94.25% vs JNJ's -50.67%.
JNJ currently has the higher Sharpe Ratio (3.42 vs 0.89), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CPRX and JNJ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer